The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial

Overview of attention for article published in The Lancet Respiratory Medicine, October 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy: 2 policy sources
twitter: 10 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 160 Dimensions

Readers on

mendeley: 142 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

Konstantinos Kostikas, 01 Dec 2014

Long-term erythromycin treatment changes the composition of respiratory microbiota in patients with bronchiectasis. In patients…

Inspire4life: connecting people with chronic lung conditions, 28 Oct 2014

Take care when using a LT macrolide in bronchiectasis patients without pseudomonas

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.